Explore practical insights and real-world perspectives on advocacy, research, and digital health. From strengthening patient engagement to driving innovation, these articles share ideas that move healthcare forward.
Healthcare today is focused on AI, digital tools, and vast datasets. But data is not enough; the real challenge is turning powerful insights into meaningful change.
In the evolving landscape of patient advocacy, professionals must amplify their voice. Our new white paper, "Bridging the Gap," provides a framework for greater impact.
The BIOADVOCATE benchmark report reveals two key "ahas" about pharma advocacy. The findings make it clear: the industry must rethink its team and budget structures.
The ELAVAY and BIOADVOCATE benchmark reports offer critical feedback to pharma from the nonprofit sector, revealing key insights for revolutionizing advocacy.
In healthcare, context is key. Social determinants of health (SDOH) significantly influence patient outcomes, and addressing them is essential for real transformation.
Patient advocacy teams play a critical role in shaping outcomes, but their own voices are often unheard. We must support these teams to amplify their real impact.
The industry has improved patient inclusion, but a seat at the table is not enough. True progress requires building systems where patients can actively participate and lead.
True healthcare innovation cannot be rooted in data alone; it demands humanity. Co-creating solutions with patients is the only way to ensure new ideas succeed.
Healthcare isn't just about data and technology; it's about people. True progress is impossible without empathy, a crucial strategic advantage in modern healthcare.
Patient inclusion is now essential, but it often becomes mere tokenism. To achieve real progress, we must move beyond formality and foster true patient partnerships.
Trust is the foundation of every meaningful healthcare interaction. In a system where it’s easily broken, rebuilding it requires a commitment to near-perfection.
Cell and gene therapies are groundbreaking medical advances. Their complexity demands flawless account management to ensure successful patient access and delivery.
In 2025, the healthcare sector faces rapid transformation. Evolving patient needs and new science demand a renewed focus on innovation and strategic collaboration.
Pharma has long promoted patient-centricity as a guiding value. Yet behind the promises, the reality is clear: patient engagement remains severely lacking.
Healthcare today is focused on AI, digital tools, and vast datasets. But data is not enough; the real challenge is turning powerful insights into meaningful change.
The BIOADVOCATE benchmark report reveals two key "ahas" about pharma advocacy. The findings make it clear: the industry must rethink its team and budget structures.
The ELAVAY and BIOADVOCATE benchmark reports offer critical feedback to pharma from the nonprofit sector, revealing key insights for revolutionizing advocacy.
True healthcare innovation cannot be rooted in data alone; it demands humanity. Co-creating solutions with patients is the only way to ensure new ideas succeed.
In 2025, the healthcare sector faces rapid transformation. Evolving patient needs and new science demand a renewed focus on innovation and strategic collaboration.
In the evolving landscape of patient advocacy, professionals must amplify their voice. Our new white paper, "Bridging the Gap," provides a framework for greater impact.
In healthcare, context is key. Social determinants of health (SDOH) significantly influence patient outcomes, and addressing them is essential for real transformation.
Patient advocacy teams play a critical role in shaping outcomes, but their own voices are often unheard. We must support these teams to amplify their real impact.
The industry has improved patient inclusion, but a seat at the table is not enough. True progress requires building systems where patients can actively participate and lead.
Healthcare isn't just about data and technology; it's about people. True progress is impossible without empathy, a crucial strategic advantage in modern healthcare.
Patient inclusion is now essential, but it often becomes mere tokenism. To achieve real progress, we must move beyond formality and foster true patient partnerships.
Trust is the foundation of every meaningful healthcare interaction. In a system where it’s easily broken, rebuilding it requires a commitment to near-perfection.
Cell and gene therapies are groundbreaking medical advances. Their complexity demands flawless account management to ensure successful patient access and delivery.
Pharma has long promoted patient-centricity as a guiding value. Yet behind the promises, the reality is clear: patient engagement remains severely lacking.
